Loading…

FGF8 protects against polymicrobial sepsis by enhancing the host's anti-infective immunity

Sepsis is characterized by a life-threatening syndrome caused by an unbalanced host response to infection. Fibroblast Growth Factor 8 (FGF8) has been newly identified to play important roles in inflammation and innate immunity, but its role in host response to sepsis is undefined. A cecal ligation a...

Full description

Saved in:
Bibliographic Details
Published in:The Journal of infectious diseases 2024-11
Main Authors: Chen, Kai, Ruan, Yanting, Ma, Wenjing, Yu, Xiaoyan, Hu, Ying, Li, Yue, Tang, Hong, Zhang, Xuemei, Yin, Yibing, Chen, Dapeng, Song, Zhixin
Format: Article
Language:English
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by
cites
container_end_page
container_issue
container_start_page
container_title The Journal of infectious diseases
container_volume
creator Chen, Kai
Ruan, Yanting
Ma, Wenjing
Yu, Xiaoyan
Hu, Ying
Li, Yue
Tang, Hong
Zhang, Xuemei
Yin, Yibing
Chen, Dapeng
Song, Zhixin
description Sepsis is characterized by a life-threatening syndrome caused by an unbalanced host response to infection. Fibroblast Growth Factor 8 (FGF8) has been newly identified to play important roles in inflammation and innate immunity, but its role in host response to sepsis is undefined. A cecal ligation and puncture (CLP) -induced mouse sepsis model was established to evaluate the immunomodulatory function of FGF8 during sepsis. The underlying molecular mechanisms were elucidated by cell models using relevant molecular biology experiments. The clinical value of FGF8 in the adjuvant diagnosis of sepsis was evaluated using clinical samples. FGF8 protein concentrations were elevated in CLP-induced septic mice compared to controls. In vivo, FGF8 blockade using anti-FGF8 antibody significantly increased mortality and bacterial burden and was paralleled by significantly aggravated tissue injury after CLP. Therapeutic administration of recombinant FGF8 (rFGF8) improved the bacterial clearance and mortality of septic mice in a FGFR1-dependent manner. In vitro, FGF8 directly enhanced bacterial phagocytosis and killing of macrophages by enhancing the phosphorylation of the ERK1/2 signaling pathway, which could be abrogated with the ERK1/2 pathway inhibitor U0126. Clinically, serum FGF8 levels in both adult and pediatric patients with sepsis from ICU were significantly higher than those in healthy controls. These results present a previously unrecognized role of FGF8 in improving survival of sepsis by enhancing host immune defense. Therefore, targeting FGF8 may provide new strategies for the diagnosis and immunotherapy of sepsis.
doi_str_mv 10.1093/infdis/jiae559
format article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_3130203311</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>3130203311</sourcerecordid><originalsourceid>FETCH-LOGICAL-c220t-4f498be816fc20da6a7fc7c6b9b666855dfc456b63e33721fb51b5a8c7a7a4203</originalsourceid><addsrcrecordid>eNo9kD1PwzAURS0EoqWwMiJvsKS14_gjI0K0IFVigYUlsh27dZU4IXaQ8u8xamF6y7lX7x4AbjFaYlSSlfO2dmF1cNJQWp6BOaaEZ4xhcg7mCOV5hkVZzsBVCAeEUEEYvwQzUlLKCsHn4HO9WQvYD100OgYod9L5EGHfNVPr9NApJxsYTB9cgGqCxu-l187vYNwbuO9CvE8hH12WHkkN7ttA17ajd3G6BhdWNsHcnO4CfKyf359esu3b5vXpcZvpPEcxK2xRCmUEZlbnqJZMcqu5ZqpUjDFBaW11QZlixBDCc2wVxYpKobnkssgRWYCHY29a8TWaEKvWBW2aRnrTjaEimKCEEYwTujyiaVkIg7FVP7hWDlOFUfXrszr6rE4-U-Du1D2q1tT_-J9A8gOZ6XSd</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>3130203311</pqid></control><display><type>article</type><title>FGF8 protects against polymicrobial sepsis by enhancing the host's anti-infective immunity</title><source>Oxford Journals Online</source><creator>Chen, Kai ; Ruan, Yanting ; Ma, Wenjing ; Yu, Xiaoyan ; Hu, Ying ; Li, Yue ; Tang, Hong ; Zhang, Xuemei ; Yin, Yibing ; Chen, Dapeng ; Song, Zhixin</creator><creatorcontrib>Chen, Kai ; Ruan, Yanting ; Ma, Wenjing ; Yu, Xiaoyan ; Hu, Ying ; Li, Yue ; Tang, Hong ; Zhang, Xuemei ; Yin, Yibing ; Chen, Dapeng ; Song, Zhixin</creatorcontrib><description>Sepsis is characterized by a life-threatening syndrome caused by an unbalanced host response to infection. Fibroblast Growth Factor 8 (FGF8) has been newly identified to play important roles in inflammation and innate immunity, but its role in host response to sepsis is undefined. A cecal ligation and puncture (CLP) -induced mouse sepsis model was established to evaluate the immunomodulatory function of FGF8 during sepsis. The underlying molecular mechanisms were elucidated by cell models using relevant molecular biology experiments. The clinical value of FGF8 in the adjuvant diagnosis of sepsis was evaluated using clinical samples. FGF8 protein concentrations were elevated in CLP-induced septic mice compared to controls. In vivo, FGF8 blockade using anti-FGF8 antibody significantly increased mortality and bacterial burden and was paralleled by significantly aggravated tissue injury after CLP. Therapeutic administration of recombinant FGF8 (rFGF8) improved the bacterial clearance and mortality of septic mice in a FGFR1-dependent manner. In vitro, FGF8 directly enhanced bacterial phagocytosis and killing of macrophages by enhancing the phosphorylation of the ERK1/2 signaling pathway, which could be abrogated with the ERK1/2 pathway inhibitor U0126. Clinically, serum FGF8 levels in both adult and pediatric patients with sepsis from ICU were significantly higher than those in healthy controls. These results present a previously unrecognized role of FGF8 in improving survival of sepsis by enhancing host immune defense. Therefore, targeting FGF8 may provide new strategies for the diagnosis and immunotherapy of sepsis.</description><identifier>ISSN: 0022-1899</identifier><identifier>ISSN: 1537-6613</identifier><identifier>EISSN: 1537-6613</identifier><identifier>DOI: 10.1093/infdis/jiae559</identifier><identifier>PMID: 39556487</identifier><language>eng</language><publisher>United States</publisher><ispartof>The Journal of infectious diseases, 2024-11</ispartof><rights>The Author(s) 2024. Published by Oxford University Press on behalf of Infectious Diseases Society of America.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><orcidid>0000-0002-0473-2941 ; 0009-0009-4095-2501</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/39556487$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Chen, Kai</creatorcontrib><creatorcontrib>Ruan, Yanting</creatorcontrib><creatorcontrib>Ma, Wenjing</creatorcontrib><creatorcontrib>Yu, Xiaoyan</creatorcontrib><creatorcontrib>Hu, Ying</creatorcontrib><creatorcontrib>Li, Yue</creatorcontrib><creatorcontrib>Tang, Hong</creatorcontrib><creatorcontrib>Zhang, Xuemei</creatorcontrib><creatorcontrib>Yin, Yibing</creatorcontrib><creatorcontrib>Chen, Dapeng</creatorcontrib><creatorcontrib>Song, Zhixin</creatorcontrib><title>FGF8 protects against polymicrobial sepsis by enhancing the host's anti-infective immunity</title><title>The Journal of infectious diseases</title><addtitle>J Infect Dis</addtitle><description>Sepsis is characterized by a life-threatening syndrome caused by an unbalanced host response to infection. Fibroblast Growth Factor 8 (FGF8) has been newly identified to play important roles in inflammation and innate immunity, but its role in host response to sepsis is undefined. A cecal ligation and puncture (CLP) -induced mouse sepsis model was established to evaluate the immunomodulatory function of FGF8 during sepsis. The underlying molecular mechanisms were elucidated by cell models using relevant molecular biology experiments. The clinical value of FGF8 in the adjuvant diagnosis of sepsis was evaluated using clinical samples. FGF8 protein concentrations were elevated in CLP-induced septic mice compared to controls. In vivo, FGF8 blockade using anti-FGF8 antibody significantly increased mortality and bacterial burden and was paralleled by significantly aggravated tissue injury after CLP. Therapeutic administration of recombinant FGF8 (rFGF8) improved the bacterial clearance and mortality of septic mice in a FGFR1-dependent manner. In vitro, FGF8 directly enhanced bacterial phagocytosis and killing of macrophages by enhancing the phosphorylation of the ERK1/2 signaling pathway, which could be abrogated with the ERK1/2 pathway inhibitor U0126. Clinically, serum FGF8 levels in both adult and pediatric patients with sepsis from ICU were significantly higher than those in healthy controls. These results present a previously unrecognized role of FGF8 in improving survival of sepsis by enhancing host immune defense. Therefore, targeting FGF8 may provide new strategies for the diagnosis and immunotherapy of sepsis.</description><issn>0022-1899</issn><issn>1537-6613</issn><issn>1537-6613</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2024</creationdate><recordtype>article</recordtype><recordid>eNo9kD1PwzAURS0EoqWwMiJvsKS14_gjI0K0IFVigYUlsh27dZU4IXaQ8u8xamF6y7lX7x4AbjFaYlSSlfO2dmF1cNJQWp6BOaaEZ4xhcg7mCOV5hkVZzsBVCAeEUEEYvwQzUlLKCsHn4HO9WQvYD100OgYod9L5EGHfNVPr9NApJxsYTB9cgGqCxu-l187vYNwbuO9CvE8hH12WHkkN7ttA17ajd3G6BhdWNsHcnO4CfKyf359esu3b5vXpcZvpPEcxK2xRCmUEZlbnqJZMcqu5ZqpUjDFBaW11QZlixBDCc2wVxYpKobnkssgRWYCHY29a8TWaEKvWBW2aRnrTjaEimKCEEYwTujyiaVkIg7FVP7hWDlOFUfXrszr6rE4-U-Du1D2q1tT_-J9A8gOZ6XSd</recordid><startdate>20241118</startdate><enddate>20241118</enddate><creator>Chen, Kai</creator><creator>Ruan, Yanting</creator><creator>Ma, Wenjing</creator><creator>Yu, Xiaoyan</creator><creator>Hu, Ying</creator><creator>Li, Yue</creator><creator>Tang, Hong</creator><creator>Zhang, Xuemei</creator><creator>Yin, Yibing</creator><creator>Chen, Dapeng</creator><creator>Song, Zhixin</creator><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><orcidid>https://orcid.org/0000-0002-0473-2941</orcidid><orcidid>https://orcid.org/0009-0009-4095-2501</orcidid></search><sort><creationdate>20241118</creationdate><title>FGF8 protects against polymicrobial sepsis by enhancing the host's anti-infective immunity</title><author>Chen, Kai ; Ruan, Yanting ; Ma, Wenjing ; Yu, Xiaoyan ; Hu, Ying ; Li, Yue ; Tang, Hong ; Zhang, Xuemei ; Yin, Yibing ; Chen, Dapeng ; Song, Zhixin</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c220t-4f498be816fc20da6a7fc7c6b9b666855dfc456b63e33721fb51b5a8c7a7a4203</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2024</creationdate><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Chen, Kai</creatorcontrib><creatorcontrib>Ruan, Yanting</creatorcontrib><creatorcontrib>Ma, Wenjing</creatorcontrib><creatorcontrib>Yu, Xiaoyan</creatorcontrib><creatorcontrib>Hu, Ying</creatorcontrib><creatorcontrib>Li, Yue</creatorcontrib><creatorcontrib>Tang, Hong</creatorcontrib><creatorcontrib>Zhang, Xuemei</creatorcontrib><creatorcontrib>Yin, Yibing</creatorcontrib><creatorcontrib>Chen, Dapeng</creatorcontrib><creatorcontrib>Song, Zhixin</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>The Journal of infectious diseases</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Chen, Kai</au><au>Ruan, Yanting</au><au>Ma, Wenjing</au><au>Yu, Xiaoyan</au><au>Hu, Ying</au><au>Li, Yue</au><au>Tang, Hong</au><au>Zhang, Xuemei</au><au>Yin, Yibing</au><au>Chen, Dapeng</au><au>Song, Zhixin</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>FGF8 protects against polymicrobial sepsis by enhancing the host's anti-infective immunity</atitle><jtitle>The Journal of infectious diseases</jtitle><addtitle>J Infect Dis</addtitle><date>2024-11-18</date><risdate>2024</risdate><issn>0022-1899</issn><issn>1537-6613</issn><eissn>1537-6613</eissn><abstract>Sepsis is characterized by a life-threatening syndrome caused by an unbalanced host response to infection. Fibroblast Growth Factor 8 (FGF8) has been newly identified to play important roles in inflammation and innate immunity, but its role in host response to sepsis is undefined. A cecal ligation and puncture (CLP) -induced mouse sepsis model was established to evaluate the immunomodulatory function of FGF8 during sepsis. The underlying molecular mechanisms were elucidated by cell models using relevant molecular biology experiments. The clinical value of FGF8 in the adjuvant diagnosis of sepsis was evaluated using clinical samples. FGF8 protein concentrations were elevated in CLP-induced septic mice compared to controls. In vivo, FGF8 blockade using anti-FGF8 antibody significantly increased mortality and bacterial burden and was paralleled by significantly aggravated tissue injury after CLP. Therapeutic administration of recombinant FGF8 (rFGF8) improved the bacterial clearance and mortality of septic mice in a FGFR1-dependent manner. In vitro, FGF8 directly enhanced bacterial phagocytosis and killing of macrophages by enhancing the phosphorylation of the ERK1/2 signaling pathway, which could be abrogated with the ERK1/2 pathway inhibitor U0126. Clinically, serum FGF8 levels in both adult and pediatric patients with sepsis from ICU were significantly higher than those in healthy controls. These results present a previously unrecognized role of FGF8 in improving survival of sepsis by enhancing host immune defense. Therefore, targeting FGF8 may provide new strategies for the diagnosis and immunotherapy of sepsis.</abstract><cop>United States</cop><pmid>39556487</pmid><doi>10.1093/infdis/jiae559</doi><orcidid>https://orcid.org/0000-0002-0473-2941</orcidid><orcidid>https://orcid.org/0009-0009-4095-2501</orcidid><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0022-1899
ispartof The Journal of infectious diseases, 2024-11
issn 0022-1899
1537-6613
1537-6613
language eng
recordid cdi_proquest_miscellaneous_3130203311
source Oxford Journals Online
title FGF8 protects against polymicrobial sepsis by enhancing the host's anti-infective immunity
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-04T19%3A35%3A29IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=FGF8%20protects%20against%20polymicrobial%20sepsis%20by%20enhancing%20the%20host's%20anti-infective%20immunity&rft.jtitle=The%20Journal%20of%20infectious%20diseases&rft.au=Chen,%20Kai&rft.date=2024-11-18&rft.issn=0022-1899&rft.eissn=1537-6613&rft_id=info:doi/10.1093/infdis/jiae559&rft_dat=%3Cproquest_cross%3E3130203311%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c220t-4f498be816fc20da6a7fc7c6b9b666855dfc456b63e33721fb51b5a8c7a7a4203%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=3130203311&rft_id=info:pmid/39556487&rfr_iscdi=true